rs145307985
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_007254.4(PNKP):c.783G>A(p.Pro261Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00511 in 1,558,080 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_007254.4 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00352 AC: 535AN: 152166Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00280 AC: 459AN: 164102Hom.: 3 AF XY: 0.00272 AC XY: 237AN XY: 87280
GnomAD4 exome AF: 0.00528 AC: 7425AN: 1405796Hom.: 24 Cov.: 31 AF XY: 0.00509 AC XY: 3533AN XY: 694180
GnomAD4 genome AF: 0.00351 AC: 535AN: 152284Hom.: 2 Cov.: 33 AF XY: 0.00304 AC XY: 226AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:5
- -
- -
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
Microcephaly, seizures, and developmental delay Benign:3
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
- -
- -
not provided Benign:2
- -
PNKP: BP4, BP7, BS2 -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Developmental and epileptic encephalopathy, 12 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at